Assessment of Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer Using MRI and 18F FDG PET/CT

Assessment of Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer Using MRI and 18F FDG PET/CT

Objective: Neoadjuvant chemotherapy (NACT) has been the primary treatment method for patients with local advanced breast cancer. A pathological complete response (pCR) to therapy correlates with better overall disease prognosis. Magnetic resonance imaging (MRI) and positron emission tomography/compu...

Full description

Bibliographic Details
Main Authors: Reem Yusuf AlBuainain, Fatema Yusuf Bunajem, Hussain Adnan Abdulla
Format: Article
Language:English
Published: Galenos Publishing House 2025-01-01
Series:European Journal of Breast Health
Subjects:
breast cancer
mri
neoadjuvant chemotherapy
pathological response
pet/ct
Online Access:https://www.eurjbreasthealth.com/articles/assessment-of-tumor-response-to-neoadjuvant-chemotherapy-in-breast-cancer-using-mri-and-lesssupgreater18lesssupgreaterf-fdg-petct/doi/ejbh.galenos.2024.2024-8-2

Internet

https://www.eurjbreasthealth.com/articles/assessment-of-tumor-response-to-neoadjuvant-chemotherapy-in-breast-cancer-using-mri-and-lesssupgreater18lesssupgreaterf-fdg-petct/doi/ejbh.galenos.2024.2024-8-2

Similar Items